# ORBERA365 Post-Marketing Clinical Follow-up Study

> **NCT04362774** · — · TERMINATED · sponsor: **Apollo Endosurgery, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DEVICE:** ORBERA365

## Key facts

- **NCT ID:** NCT04362774
- **Lead sponsor:** Apollo Endosurgery, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-23
- **Primary completion:** 2023-02-21
- **Final completion:** 2023-10-10
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Study was stopped after 1 site completed follow-up of enrolled patients, no other sites were opened in the study.
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362774, "ORBERA365 Post-Marketing Clinical Follow-up Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04362774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*